Drug
Deuruxolitinib
Deuruxolitinib: highest development phase Phase 3, developed by Sun Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Deuruxolitinib NCT07617597 | Phase 3 | Alopecia Areata |
Latest
No recent events.
Follow Deuruxolitinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.